loading
Precedente Chiudi:
$7.32
Aprire:
$7.32
Volume 24 ore:
1.06M
Relative Volume:
0.56
Capitalizzazione di mercato:
$2.32B
Reddito:
$2.68B
Utile/perdita netta:
$-184.45M
Rapporto P/E:
-10.88
EPS:
-0.6805
Flusso di cassa netto:
$229.23M
1 W Prestazione:
+3.42%
1M Prestazione:
-7.09%
6M Prestazione:
-13.60%
1 anno Prestazione:
+10.85%
Intervallo 1D:
Value
$7.26
$7.415
Intervallo di 1 settimana:
Value
$7.19
$7.41
Portata 52W:
Value
$6.29
$9.475

Amneal Pharmaceuticals Inc Stock (AMRX) Company Profile

Name
Nome
Amneal Pharmaceuticals Inc
Name
Telefono
908-947-3120
Name
Indirizzo
400 Crossing Boulevard, 3rd Floor, Bridgewater
Name
Dipendente
5,210
Name
Cinguettio
@amnealpharma
Name
Prossima data di guadagno
2025-05-02
Name
Ultimi documenti SEC
Name
AMRX's Discussions on Twitter

Confronta AMRX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
AMRX
Amneal Pharmaceuticals Inc
7.415 2.28B 2.68B -184.45M 229.23M -0.6805
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
11.41 50.54B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
169.10 74.02B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
RDHL
Redhill Biopharma Ltd Adr
1.79 4.22M 35.75M 11.57M -26.25M -3.8069
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.03 45.82B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
17.14 20.31B 16.54B -1.64B 749.00M -1.45

Amneal Pharmaceuticals Inc Stock (AMRX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-02-24 Aggiornamento JP Morgan Neutral → Overweight
2024-09-06 Aggiornamento JP Morgan Underweight → Neutral
2021-04-07 Ripresa RBC Capital Mkts Sector Perform
2021-03-08 Aggiornamento Goldman Sell → Buy
2020-12-14 Aggiornamento Barclays Equal Weight → Overweight
2020-12-14 Aggiornamento Guggenheim Neutral → Buy
2020-07-27 Iniziato Goldman Sell
2020-05-12 Aggiornamento Guggenheim Sell → Neutral
2019-12-12 Downgrade Raymond James Outperform → Mkt Perform
2019-11-12 Downgrade JP Morgan Neutral → Underweight
2019-11-07 Downgrade SVB Leerink Outperform → Mkt Perform
2019-07-22 Aggiornamento SVB Leerink Mkt Perform → Outperform
2019-07-11 Downgrade RBC Capital Mkts Outperform → Sector Perform
2019-07-08 Aggiornamento Piper Jaffray Neutral → Overweight
2019-06-11 Iniziato Barclays Equal Weight
2019-05-21 Aggiornamento Raymond James Mkt Perform → Strong Buy
2019-03-20 Iniziato SunTrust Buy
2019-03-08 Downgrade SVB Leerink Outperform → Mkt Perform
2018-12-14 Downgrade Morgan Stanley Overweight → Equal-Weight
2018-10-16 Downgrade SunTrust Buy → Hold
2018-08-13 Aggiornamento RBC Capital Mkts Sector Perform → Outperform
2018-07-23 Iniziato Morgan Stanley Overweight
2018-06-22 Iniziato B. Riley FBR, Inc. Buy
Mostra tutto

Amneal Pharmaceuticals Inc Borsa (AMRX) Ultime notizie

pulisher
May 29, 2025

Amneal to Participate at Upcoming Investor Conferences in June - GlobeNewswire

May 29, 2025
pulisher
May 29, 2025

Amneal CEO and CFO Set for Exclusive Presentations at Two Major Healthcare Investor Conferences - Stock Titan

May 29, 2025
pulisher
May 29, 2025

Bank of America Corp DE Has $4.41 Million Position in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) - Defense World

May 29, 2025
pulisher
May 28, 2025

FDA approves Amneal’s DHE migraine/cluster headache autoinjector - MSN

May 28, 2025
pulisher
May 28, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $716,000 Holdings in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) - Defense World

May 28, 2025
pulisher
May 27, 2025

Pharyngitis Treatment Market with Antibiotics and Home - openPR.com

May 27, 2025
pulisher
May 26, 2025

3 Reasons Growth Investors Will Love Amneal (AMRX) - Yahoo Finance

May 26, 2025
pulisher
May 26, 2025

Deutsche Bank AG Has $1.06 Million Stock Holdings in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) - Defense World

May 26, 2025
pulisher
May 22, 2025

Hydroxychloroquine Market to Witness Remarkable Growth with - openPR.com

May 22, 2025
pulisher
May 22, 2025

Insider Sell: Nikita Shah Sells Shares of Amneal Pharmaceuticals Inc (AMRX) - GuruFocus

May 22, 2025
pulisher
May 21, 2025

Migraine Market Enters New Era Following Satsuma Pharmaceuticals' ATZUMI and Amneal Pharmaceuticals' BREKIYA Regulatory Approval | DelveInsight - PR Newswire

May 21, 2025
pulisher
May 20, 2025

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Shares Purchased by BNP Paribas Financial Markets - Defense World

May 20, 2025
pulisher
May 19, 2025

Ameriprise Financial Inc. Sells 49,121 Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) - Defense World

May 19, 2025
pulisher
May 16, 2025

Amneal gets U.S. FDA nod for Brekiya as a migraine treatment - MSN

May 16, 2025
pulisher
May 16, 2025

US FDA approves Amneal's self-administered migraine treatment - Reuters

May 16, 2025
pulisher
May 16, 2025

AMRX Q1 Earnings Call: Miss on Revenue, Margin Expansion, and Product Pipeline Progress - Yahoo Finance

May 16, 2025
pulisher
May 16, 2025

Amneal Gets FDA Nod For Self-Administrable Migraine Injection - MSN

May 16, 2025
pulisher
May 16, 2025

The Manufacturers Life Insurance Company Has $689,000 Stake in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) - Defense World

May 16, 2025
pulisher
May 16, 2025

Amneal gets FDA approval for Brekiya to treat migraine and cluster headaches - World Pharmaceutical Frontiers

May 16, 2025
pulisher
May 16, 2025

Amneal’s Brekiya autoinjector approved by FDA for migraines - Investing.com Nigeria

May 16, 2025
pulisher
May 16, 2025

Northern Trust Corp Purchases 156,699 Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) - Defense World

May 16, 2025
pulisher
May 15, 2025

Amneal’s Brekiya autoinjector approved by FDA for migraines By Investing.com - Investing.com South Africa

May 15, 2025
pulisher
May 15, 2025

Amneal Gets FDA Nod For Self-Administrable Migraine Injection By Stocktwits - Investing.com India

May 15, 2025
pulisher
May 15, 2025

FDA Approves Amneal's (AMRX) Brekiya Autoinjector for Migraine R - GuruFocus

May 15, 2025
pulisher
May 15, 2025

US FDA approves Amneal’s self-administered migraine treatment - 1470 & 100.3 WMBD

May 15, 2025
pulisher
May 15, 2025

FDA Greenlights Amneal's (AMRX) Innovative Migraine Treatment | AMRX Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Amneal Pharmaceuticals' Brekiya Approved by FDA - marketscreener.com

May 15, 2025
pulisher
May 15, 2025

Amneal rises after US FDA greenlights self-administered migraine treatment - TradingView

May 15, 2025
pulisher
May 15, 2025

Amneal Receives U.S. FDA Approval for Brekiya® (dihydroergotamine mesylate) injection for the Acute Treatment of Migraine and Cluster Headaches in Adults - The Manila Times

May 15, 2025
pulisher
May 15, 2025

US FDA approves Amneal's migraine treatment - marketscreener.com

May 15, 2025
pulisher
May 15, 2025

Amneal Receives U.S. FDA Approval for Brekiya® - GlobeNewswire

May 15, 2025
pulisher
May 15, 2025

Breakthrough: First At-Home Injectable Migraine Treatment Gets FDA Green LightWhat Makes It Different - Stock Titan

May 15, 2025
pulisher
May 15, 2025

This Insider Has Just Sold Shares In Amneal Pharmaceuticals - simplywall.st

May 15, 2025
pulisher
May 15, 2025

Amneal Pharmaceuticals (NASDAQ:AMRX) Stock Rating Lowered by StockNews.com - Defense World

May 15, 2025
pulisher
May 13, 2025

Director John Kiely Sells 50,000 Shares of Amneal Pharmaceuticals Inc (AMRX) - GuruFocus

May 13, 2025
pulisher
May 12, 2025

Amneal Proud To Be ‘Made In America’ And Ready To Scale Up Its US Manufacturing - insights.citeline.com

May 12, 2025
pulisher
May 12, 2025

Key Trends Shaping the Future of Filgrastim Biosimilars Market: Amneal Pharmaceuticals' Fylnetra Marks A Ne... - WhaTech

May 12, 2025
pulisher
May 10, 2025

Are Options Traders Betting on a Big Move in Amneal Pharmaceuticals Stock? - MSN

May 10, 2025
pulisher
May 10, 2025

Amneal Announces Submission of New Drug Application to the U.S. FDA for IPX203 for the Treatment of Parkinson’s Disease - Business Wire

May 10, 2025
pulisher
May 09, 2025

Amneal Pharmaceuticals to add 200 jobs at its Brookhaven factory - Newsday

May 09, 2025
pulisher
May 09, 2025

Does Amneal (AMRX) Have the Potential to Rally 54.16% as Wall Street Analysts Expect? - Yahoo Finance

May 09, 2025
pulisher
May 09, 2025

Amneal and Apiject join forces to boost US pharmaceutical manufacturing - World Pharmaceutical Frontiers

May 09, 2025
pulisher
May 09, 2025

Decoding Amneal Pharmaceuticals Inc (AMRX): A Strategic SWOT Ins - GuruFocus

May 09, 2025
pulisher
May 08, 2025

Amneal Pharmaceuticals Approves Key Proposals at Annual Meeting - TipRanks

May 08, 2025
pulisher
May 08, 2025

Here is Why Growth Investors Should Buy Amneal (AMRX) Now - Yahoo Finance

May 08, 2025
pulisher
May 08, 2025

Are Options Traders Betting On A Big Move In Amneal Pharmaceuticals Stock? - Barchart.com

May 08, 2025
pulisher
May 08, 2025

Amneal and Apiject to Expand Sterile and Blow-Fill-Seal - GlobeNewswire

May 08, 2025
pulisher
May 08, 2025

Amneal and Apiject to Expand Sterile and Blow-Fill-Seal (BFS) Capabilities for Advanced ... - Bluefield Daily Telegraph

May 08, 2025

Amneal Pharmaceuticals Inc Azioni (AMRX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
drug_manufacturers_specialty_generic HCM
$13.57
price down icon 3.31%
drug_manufacturers_specialty_generic RDY
$14.65
price down icon 0.51%
$124.33
price up icon 0.59%
drug_manufacturers_specialty_generic RGC
$950.00
price up icon 4.05%
$324.55
price up icon 1.79%
$17.09
price up icon 1.69%
Capitalizzazione:     |  Volume (24 ore):